| Autor: |
F. Ruythooren, S. Ghijselings, M. Depypere, W.-J. Metsemakers, L. Henckaerts, N. Noppe, G. Vles |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Journal of Bone and Joint Infection, Vol 9, Pp 167-171 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2206-3552 |
| DOI: |
10.5194/jbji-9-167-2024 |
| Popis: |
Ocrelizumab – a monoclonal anti-CD20 antibody used in treatment of multiple sclerosis (MS) – marks significant progress in treating autoimmune diseases but raises susceptibility to opportunistic infections due to hypogammaglobulinemia. A young MS patient developed osteomyelitis from persistent Ureaplasma urealyticum urethritis, which was diagnosed with specialized polymerase chain reaction and resolved with targeted antibiotics. A multidisciplinary approach is crucial for managing such infections. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
